NCT01311037Unknown不适用
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer A Prospective Trial
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 2
- 试验地点
- 1
研究概览
简要总结
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women with Advanced Breast Cancer A Prospective Trial.
详细描述
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women with Advanced Breast Cancer A Prospective Trial.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 45 Years 至 85 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Receptor Positive Premenopausal Women with Advanced Breast Cancer.
排除标准
- •Any woman other than diagnosis of Receptor Positive Premenopausal with Advanced Breast Cancer.
研究者
研究点 (1)
Loading locations...
相似试验
招募中
2 期
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial CancerEndometrial Neoplasm Malignant Stage INCT05247268Fudan University104
终止
2 期
Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian FailureBreast CancerNCT00555477University of Michigan Rogel Cancer Center69
尚未招募
1 期
Effect of aromatase inhibitor with LH-RH agonisit for tamoxifen resistant recurrent breast cancerRecurrent breast cancerJPRN-UMIN000004365The University of Tokushima graduate school50
招募中
2 期
A GnRH Agonist IN pre-menopausal women STudy to treat severe Polycystic Liver DiseaseCystic livers100198061001965410038430Polycystic liver diseaseNL-OMON50796niversitair Medisch Centrum Groningen18
已完成
3 期
The AGAINST-PLD Study; An investigator-driven, randomized, open label clinical trial assessing efficacy of leuprorelin to halt disease progression in PLDpolycystic liver disease2023-506637-30-00Universitair Medisch Centrum Groningen36